TCBP
Income statement / Annual
Last year (2023), TC Biopharm (Holdings) Plc's total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, TC Biopharm (Holdings) Plc's net income was -$5.91 M.
See TC Biopharm (Holdings) Plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$3.84 M |
$1.98 M |
$1.98 M |
$3.43 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$3.84 M
|
$1.98 M
|
$1.98 M
|
$3.43 M
|
| Gross Profit Ratio |
0
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$7.77 M
|
$7.59 M
|
$6.16 M
|
$6.68 M
|
$8.61 M
|
| General & Administrative Expenses |
$6.47 M
|
$8.34 M
|
$3.11 M
|
$2.21 M
|
$3.01 M
|
| Selling & Marketing Expenses |
$402.31 K
|
$402.31 K
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.87 M
|
$8.74 M
|
$3.11 M
|
$2.21 M
|
$3.01 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$6.91 M
|
$124.90 K
|
$13.52 M
|
$8.32 M
|
$10.07 M
|
| Cost And Expenses |
$6.91 M
|
$124.90 K
|
$13.52 M
|
$8.32 M
|
$10.07 M
|
| Interest Income |
$83.03 K
|
$6.75 M
|
$3.44 M
|
$291.03 K
|
$253.51 K
|
| Interest Expense |
$0.00
|
$6.75 M
|
$3.44 M
|
$292.06 K
|
$275.41 K
|
| Depreciation & Amortization |
$630.06 K
|
$762.47 K
|
$811.96 K
|
$878.64 K
|
$721.93 K
|
| EBITDA |
-$13.61 M |
-$11.32 M |
-$6.48 M |
-$5.26 M |
-$5.92 M |
| EBITDA Ratio |
0
|
-2.94
|
-3.27
|
-2.66
|
-1.73
|
| Operating Income Ratio |
0
|
-3.14
|
-3.68
|
-3.48
|
-1.94
|
| Total Other Income/Expenses Net |
$7.24 M
|
$9.05 M
|
-$7.70 M
|
-$291.03 K
|
-$253.51 K
|
| Income Before Tax |
-$7.00 M
|
-$3.03 M
|
-$14.98 M
|
-$6.63 M
|
-$6.89 M
|
| Income Before Tax Ratio |
0
|
-0.79
|
-7.57
|
-3.35
|
-2.01
|
| Income Tax Expense |
-$1.09 M
|
$1.72 M
|
$1.41 M
|
$1.17 M
|
$826.07 K
|
| Net Income |
-$5.91 M
|
-$1.31 M
|
-$13.58 M
|
-$5.46 M
|
-$6.07 M
|
| Net Income Ratio |
0
|
-0.34
|
-6.86
|
-2.76
|
-1.77
|
| EPS |
-9.56 |
-19.12 |
-82488 |
-124 |
-138 |
| EPS Diluted |
-9.56 |
-19.12 |
-82488 |
-124 |
-138 |
| Weighted Average Shares Out |
$617.84 K
|
$68.72 K
|
$39.06 K
|
$56.12 K
|
$56.12 K
|
| Weighted Average Shares Out Diluted |
$617.84 K
|
$68.72 K
|
$39.06 K
|
$56.12 K
|
$56.12 K
|
| Link |
|
|
|
|
|
